Skip to main content

Advertisement

Log in

Ethical considerations in the relief of cancer pain

  • Review
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

The management of pain for patients with cancer and cancer survivors is a critical clinical task that involves a multitude of ethical issues at almost every phase of the cancer experience. This review is divided into three sections: In the first, we address rights and duties in the relief of pain from the perspective of patients, clinicians, health care institutions and organizations, and public policy. This section includes a detailed description of issues and duties in relation to opioid misuse and addiction. In the second section, we discuss the ethical consideration of therapeutic planning. The final section addresses ethical considerations in the management of pain at the end of life including a detailed discussion regarding ethical issues relating to the use of palliative sedation as a clinical intervention of last resort.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data availability

Not relevant

References

  1. International Pain Summit of the International Association for the Study of Pain (2011) Declaration of Montreal: declaration that access to pain management is a fundamental human right. J Pain Palliat Care Pharmacother 25(1):29–31

    CAS  PubMed  Google Scholar 

  2. Lohman D, Schleifer R, Amon JJ (2010) Access to pain treatment as a human right. BMC Med 8:8

    PubMed Central  PubMed  Google Scholar 

  3. Brennan F, Lohman D, Gwyther L (2019) Access to pain management as a human right. Am J Public Health 109(1):61–65

    PubMed Central  PubMed  Google Scholar 

  4. Goudas LC, Bloch R, Gialeli-Goudas M, Lau J, Carr DB (2005) The epidemiology of cancer pain. Cancer Invest 23(2):182–190

    PubMed  Google Scholar 

  5. van den Beuken-van EM, de Rijke J, Kessels A, Schouten H, van Kleef M, Patijn J (2007) Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 18:1437–1449

    Google Scholar 

  6. Marcus DA (2011) Epidemiology of cancer pain. Curr Pain Headache Rep 15(4):231–234

    PubMed  Google Scholar 

  7. Solano JP, Gomes B, Higginson IJ (2006) A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage 31(1):58–69

    PubMed  Google Scholar 

  8. Ostgathe C, Alt-Epping B, Golla H, Gaertner J, Lindena G, Radbruch L et al (2011) Non-cancer patients in specialized palliative care in Germany: what are the problems? Palliat Med 25(2):148–152

    PubMed  Google Scholar 

  9. Chang VT, Janjan N, Jain S, Chau C (2006) Update in cancer pain syndromes. J Palliat Med 9(6):1414–1434

    PubMed  Google Scholar 

  10. Caraceni A, Portenoy RK (1999) An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain. 82(3):263–274

    PubMed  Google Scholar 

  11. Chapman S (2011) Chronic pain syndromes in cancer survivors. Nurs Stand 25(21):35–41

    PubMed  Google Scholar 

  12. Stull DM, Hollis LS, Gregory RE, Sheidler VR, Grossman SA (1996) Pain in a comprehensive cancer center: more frequently due to treatment than underlying tumor (meeting abstract). Proc Annu Meet Am Soc Clin Oncol 15:1717

    Google Scholar 

  13. Jain PN, Chatterjee A (2010) Development of acute pain service in an Indian cancer hospital. J Pain Palliat Care Pharmacother 24(2):129–135

    CAS  PubMed  Google Scholar 

  14. Sanford NN, Sher DJ, Butler SS, Xu X, Ahn C, Aizer AA et al (2019) Prevalence of chronic pain among cancer survivors in the United States, 2010-2017. Cancer 125(23):4310–4318

    PubMed  Google Scholar 

  15. Gallaway MS, Townsend JS, Shelby D, Puckett MC (2020) Peer reviewed: pain among cancer survivors. Prev Chronic Dis 17

  16. Brennan F, Carr DB, Cousins M (2007) Pain management: a fundamental human right. Anesth Analg 105(1):205–221

    PubMed  Google Scholar 

  17. Cousins MJ, Brennan F, Carr DB (2004) Pain relief: a universal human right. Pain. 112(1-2):1–4

    PubMed  Google Scholar 

  18. Alford DP, Zisblatt L, Ng P, Hayes SM, Peloquin S, Hardesty I et al (2016) SCOPE of pain: an evaluation of an opioid risk evaluation and mitigation strategy continuing education program. Pain Med 17(1):52–63

    PubMed Central  PubMed  Google Scholar 

  19. Anghelescu DL, Ehrentraut JH, Faughnan LG (2013) Opioid misuse and abuse: risk assessment and management in patients with cancer pain. J Natl Compr Canc Netw 11(8):1023–1031

    CAS  PubMed  Google Scholar 

  20. Alford DP, Lazure P, Murray S, Hardesty I, Krause JR, White JL (2019) National trends in prescription opioid risk mitigation practices: implications for prescriber education. Pain Med 20(5):907–915

    PubMed  Google Scholar 

  21. Phillips DM (2000) JCAHO pain management standards are unveiled. JAMA. 284(4):428–429

    CAS  PubMed  Google Scholar 

  22. Post LF, Blustein J, Gordon E, Dubler NN (1996) Pain: ethics, culture, and informed consent to relief. J Law Med Ethics 24(4):348–359

    CAS  PubMed  Google Scholar 

  23. Starrels JL, Becker WC, Weiner MG, Li X, Heo M, Turner BJ (2011) Low use of opioid risk reduction strategies in primary care even for high risk patients with chronic pain. J Gen Intern Med 26(9):958–964

    PubMed Central  PubMed  Google Scholar 

  24. Grant KJ, Baca CT (2010) Methadone deaths in pain and addiction populations. J Gen Intern Med 25(9):898 author reply 9

    PubMed Central  PubMed  Google Scholar 

  25. Manchikanti KN, Manchikanti L, Damron KS, Pampati V, Fellows B (2008) Increasing deaths from opioid analgesics in the United States: an evaluation in an interventional pain management practice. J Opioid Manag 4(5):271–283

    PubMed  Google Scholar 

  26. Bennett MI, Eisenberg E, Ahmedzai SH, Bhaskar A, O’Brien T, Mercadante S et al (2019) Standards for the management of cancer-related pain across Europe—a position paper from the EFIC Task Force on Cancer Pain. Eur J Pain 23(4):660–668

    PubMed Central  PubMed  Google Scholar 

  27. Rich BA, Dubois M (2011) Pain, ethics, and public policy. Pain Med 12(9):1295–1296

    PubMed  Google Scholar 

  28. Volkow ND, Blanco C (2021) The changing opioid crisis: development, challenges and opportunities. Mol Psychiatry 26(1):218–233

    PubMed  Google Scholar 

  29. Volkow ND, Collins FS (2017) The role of science in addressing the opioid crisis. N Engl J Med 377(4):391–394

    PubMed  Google Scholar 

  30. Vadivelu N, Kai AM, Kodumudi V, Sramcik J, Kaye AD (2018) The opioid crisis: a comprehensive overview. Curr Pain Headache Rep 22(3):1–6

    Google Scholar 

  31. The International Narcotics Control Board. Report 2021. Vienna: International Narcotics Control Board (UN) 2022.

  32. Cleary J, Powell RA, Munene G, Mwangi-Powell FN, Luyirika E, Kiyange F et al (2013) Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Africa: a report from the Global Opioid Policy Initiative (GOPI). Ann Oncol 24:xi14–xi23

    PubMed  Google Scholar 

  33. Cleary J, Radbruch L, Torode J, Cherny NI (2013) Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Asia: a report from the Global Opioid Policy Initiative (GOPI). Ann Oncol 24:xi24–xi32

    PubMed  Google Scholar 

  34. Cleary J, Simha N, Panieri A, Scholten W, Radbruch L, Torode J et al (2013) Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in India: a report from the Global Opioid Policy Initiative (GOPI). Ann Oncol 24:xi33–xi40

    PubMed  Google Scholar 

  35. Cleary J, De Lima L, Eisenchlas J, Radbruch L, Torode J, Cherny NI (2013) Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Latin America and the Caribbean: a report from the Global Opioid Policy Initiative (GOPI). Ann Oncol 24:xi41–xi50

    PubMed  Google Scholar 

  36. Cleary J, DeLima L, Eisenchlas J, Scholten W, Radbruch L, Torode J et al (2013) Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Africa: a report from the Global Opioid Policy Initiative (GOPI). Ann Oncol 24(Supplement 11):14–23

    Google Scholar 

  37. Cherny NI, Cleary J, Scholten W, Radbruch L, Torode J (2013) The Global Opioid Policy Initiative (GOPI) project to evaluate the availability and accessibility of opioids for the management of cancer pain in Africa, Asia, Latin America and the Caribbean, and the Middle East: introduction and methodology. Ann Oncol 24(Supplement 11):xi7–xi13

    PubMed  Google Scholar 

  38. Cleary J, DeLima L, Eisenchlas J, Scholten W, Radbruch L, Torode J et al (2013) Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in the Caribbean and Latin America: a report from the Global Opioid Policy Initiative (GOPI). Ann Oncol 24(Supplement 11):41–50

    Google Scholar 

  39. Knaul FM, Bhadelia A, Rodriguez NM, Arreola-Ornelas H, Zimmermann C (2018) The Lancet Commission on Palliative Care and Pain Relief—findings, recommendations, and future directions. Lancet Glob Health 6:S5–S6

    Google Scholar 

  40. De Lima L, Radbruch L (2018) The International Association for hospice and palliative care: advancing hospice and palliative care worldwide. J Pain Symptom Manage 55(2):S96–S103

    PubMed  Google Scholar 

  41. Osman H, Shrestha S, Temin S, Ali ZV, Corvera RA, Ddungu HD et al (2018) Palliative care in the global setting: ASCO resource-stratified practice guideline. J Glob Oncol 4:1–24

    PubMed  Google Scholar 

  42. Donkor A, Luckett T, Aranda S, Phillips J (2018) Barriers and facilitators to implementation of cancer treatment and palliative care strategies in low-and middle-income countries: systematic review. Int J Public Health 63(9):1047–1057

    PubMed  Google Scholar 

  43. Caraceni A, Shkodra M (2019) Cancer pain assessment and classification. Cancers (Basel) 11(4):510

    PubMed  Google Scholar 

  44. Kumar G, Markert RJ, Patel R (2011) Assessment of hospice patients’ goals of care at the end of life. Am J Hosp Palliat Care 28(1):31–34

    PubMed  Google Scholar 

  45. Haberle TH, Shinkunas LA, Erekson ZD, Kaldjian LC (2011) Goals of care among hospitalized patients: a validation study. Am J Hosp Palliat Care 28(5):335–341

    PubMed  Google Scholar 

  46. Kaldjian LC, Curtis AE, Shinkunas LA, Cannon KT (2008) Goals of care toward the end of life: a structured literature review. Am J Hosp Palliat Care 25(6):501–511

    PubMed  Google Scholar 

  47. Duggleby W, Berry P (2005) Transitions and shifting goals of care for palliative patients and their families. Clin J Oncol Nurs 9(4):425–428

    PubMed  Google Scholar 

  48. Cherny N, Portenoy R (2021) Core concepts in palliative care. In: Cherny N, Currow D, Fallon M, Portenoy R, Kaasa S (eds) Oxfortd Textbook of Palliative Medicine, 6th edn. Oxford University Press, London, pp 44–54

    Google Scholar 

  49. Breivik H, Cherny N, Collett B, de Conno F, Filbet M, Foubert AJ et al (2009) Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol 20(8):1420–1433

    CAS  PubMed  Google Scholar 

  50. Fisch MJ, Lee JW, Weiss M, Wagner LI, Chang VT, Cella D et al (2012) Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol 30(16):1980–1988

    PubMed Central  PubMed  Google Scholar 

  51. Wu HS, Natavio T, Davis JE, Yarandi HN (2013) Pain in outpatients treated for breast cancer: prevalence, pharmacological treatment, and impact on quality of life. Cancer Nurs 36(3):229–235

    PubMed  Google Scholar 

  52. Moskovitz BL, Benson CJ, Patel AA, Chow W, Mody SH, McCarberg BH et al (2011) Analgesic treatment for moderate-to-severe acute pain in the United States: patients’ perspectives in the Physicians Partnering Against Pain (P3) survey. J Opioid Manag 7(4):277–286

    PubMed  Google Scholar 

  53. Foley KM (2011) How well is cancer pain treated? Palliat Med 25(5):398–401

    PubMed  Google Scholar 

  54. Cohen MZ, Musgrave CF, Munsell MF, Mendoza TR, Gips M (2005) The cancer pain experience of Israeli and American patients 65 years and older. J Pain Symptom Manage 30(3):254–263

    PubMed  Google Scholar 

  55. Von Roenn JH, Cleeland CS, Gonin R, Hatfield AK, Pandya KJ (1993) Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med 119(2):121–126

    Google Scholar 

  56. Darawad M, Alnajar MK, Abdalrahim MS, El-Aqoul AM (2019) Cancer pain management at oncology units: comparing knowledge, attitudes and perceived barriers between physicians and nurses. J Cancer Educ 34(2):366–374

    PubMed  Google Scholar 

  57. Koyyalagunta D, Burton AW, Toro MP, Driver L, Novy DM (2011) Opioid abuse in cancer pain: report of two cases and presentation of an algorithm of multidisciplinary care. Pain Physician 14(4):E361–E371

    PubMed  Google Scholar 

  58. Starr TD, Rogak LJ, Passik SD (2010) Substance abuse in cancer pain. Curr Pain Headache Rep 14(4):268–275

    PubMed  Google Scholar 

  59. Jairam V, Yang DX, Verma V, James BY, Park HS (2020) National patterns in prescription opioid use and misuse among cancer survivors in the United States. JAMA Netw Open 3(8):e2013605

    PubMed Central  PubMed  Google Scholar 

  60. Højsted J, Sjøgren P (2007) Addiction to opioids in chronic pain patients: a literature review. Eur J Pain 11(5):490–518

    PubMed  Google Scholar 

  61. Kwon JH, Hui D, Bruera E (2015) A pilot study to define chemical coping in cancer patients using the Delphi method. J Palliat Med 18(8):703–706

    PubMed Central  PubMed  Google Scholar 

  62. Castaneda AM, Lee CS, Kim YC, Lee D, Moon JY (2018) Addressing opioid-related chemical coping in long-term opioid therapy for chronic noncancer pain: a multicenter, observational, cross-sectional study. J Clin Med 7(10):354

    CAS  PubMed Central  PubMed  Google Scholar 

  63. Strang J, Volkow ND, Degenhardt L, Hickman M, Johnson K, Koob GF et al (2020) Opioid use disorder. Nat Rev Dis Primers 6(1):1–28

    Google Scholar 

  64. Schuckit MA (2016) Treatment of opioid-use disorders. N Engl J Med 375(4):357–368

    PubMed  Google Scholar 

  65. Gorfinkel L, Voon P, Wood E, Klimas J (2018) Diagnosing opioid addiction in people with chronic pain. BMJ:k3949

  66. Preux C, Bertin M, Tarot A, Authier N, Pinol N, Brugnon D et al (2022) Prevalence of opioid use disorder among patients with cancer-related pain: a systematic review. J Clin Med 11(6):1594

    PubMed Central  PubMed  Google Scholar 

  67. Savage SR, Joranson DE, Covington EC, Schnoll SH, Heit HA, Gilson AM (2003) Definitions related to the medical use of opioids: evolution towards universal agreement. J Pain Symptom Manage 26(1):655–667

    PubMed  Google Scholar 

  68. Kosten TR, Baxter LE (2019) Effective management of opioid withdrawal symptoms: a gateway to opioid dependence treatment. Am J Addict 28(2):55–62

    PubMed Central  PubMed  Google Scholar 

  69. Covington EC, Argoff CE, Ballantyne JC, Cowan P, Gazelka HM, Hooten WM et al (2020) Ensuring patient protections when tapering opioids: consensus panel recommendations. In: Mayo Clinic Proceedings. Elsevier 95(10):2155–2171

  70. Kwon JH, Tanco K, Hui D, Reddy A, Bruera E (2014) Chemical coping versus pseudoaddiction in patients with cancer pain. Palliat Support Care 12(5):413–417

    PubMed  Google Scholar 

  71. Bell K, Salmon A (2009) Pain, physical dependence and pseudoaddiction: redefining addiction for ‘nice’ people? Int J Drug Policy 20(2):170–178

    PubMed  Google Scholar 

  72. Cagle JG, McPherson ML, Frey JJ, Sacco P, Ware OD, Wiegand DL et al (2020) Estimates of medication diversion in hospice. JAMA. 323(6):566–568

    PubMed Central  PubMed  Google Scholar 

  73. Berde C, Nurko S (2008) Opioid side effects--mechanism-based therapy. N Engl J Med 358(22):2400–2402

    CAS  PubMed  Google Scholar 

  74. Cherny N, Ripamonti C, Pereira J, Davis C, Fallon M, McQuay H et al (2001) Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 19(9):2542–2554

    CAS  PubMed  Google Scholar 

  75. Centers for Disease Control and Prevention (CDC) (2012) Vital signs: risk for overdose from methadone used for pain relief - United States, 1999-2010. Morb Mortal Wkly Rep 61(26):493–497

    Google Scholar 

  76. Minogue B (2000) The two fundamental duties of the physician. Acad Med 75(5):431–442

    CAS  PubMed  Google Scholar 

  77. Benzar E, Hansen L, Kneitel AW, Fromme EK (2011) Discharge planning for palliative care patients: a qualitative analysis. J Palliat Med 14(1):65–69

    PubMed Central  PubMed  Google Scholar 

  78. Mor V, Besdine RW (2011) Policy options to improve discharge planning and reduce rehospitalization. JAMA. 305(3):302–303

    CAS  PubMed Central  PubMed  Google Scholar 

  79. Anil N, Smallwood N, Dunn S (2022) Opioids in advanced lung malignancy: a clinical audit of opioid prescription, patient education and safeguarding. Intern Med J 52(10):1698–1706

    CAS  PubMed  Google Scholar 

  80. Lacey J, Cherny N (2021) Management of the actively dying patient. In: Cherny N, Currow D, Fallon M, Portenoy R, Kaasa S (eds) Oxfortd Textbook of Palliative Medicine, 6th edn. Oxford University Press, London

    Google Scholar 

  81. Hagarty AM, Bush SH, Talarico R, Lapenskie J, Tanuseputro P (2020) Severe pain at the end of life: a population-level observational study. BMC Palliat Care 19(1):1–13

    Google Scholar 

  82. Clark K, Smith J, Lovell M, Currow DC (2012) Longitudinal pain reports in a palliative care population. J Palliat Med 15(12):1335–1341

    PubMed  Google Scholar 

  83. Cherny NI, Radbruch L (2009) European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med 23(7):581–593

    PubMed  Google Scholar 

  84. Pauker SG, Kassirer JP (1980) The threshold approach to clinical decision-making. N Engl J Med 302(20):1109–1117

    CAS  PubMed  Google Scholar 

  85. Blinderman CD (2012) Do surrogates have a right to refuse pain medications for incompetent patients? J Pain Symptom Manage 43(2):299–305

    PubMed  Google Scholar 

  86. Miller FG, Fins JJ, Bacchetta MD (1996) Clinical pragmatism: John Dewey and clinical ethics. J Contemp Health Law Policy 13(1):27–51

    CAS  PubMed  Google Scholar 

  87. Fins JJ, Bacchetta MD, Miller FG (1997) Clinical pragmatism: a method of moral problem solving. Kennedy Inst Ethics J 7:129–145

    PubMed  Google Scholar 

  88. Gevers S (2003) Terminal sedation: a legal approach. Eur J Health Law 10(4):359–367

    PubMed  Google Scholar 

  89. Devlin P (1985) Easing the passing. Bodley Head, London

    Google Scholar 

  90. Burt RA (1997) The Supreme Court speaks--not assisted suicide but a constitutional right to palliative care. N Engl J Med 337(17):1234–1236

    CAS  PubMed  Google Scholar 

  91. Boyle J (2004) Medical ethics and double effect: the case of terminal sedation. Theor Med Bioeth 25(1):51–60

    PubMed  Google Scholar 

  92. Quill TE, Dresser R, Brock DW (1997) The rule of double effect--a critique of its role in end-of-life decision making. N Engl J Med 337(24):1768–1771

    CAS  PubMed  Google Scholar 

  93. Materstvedt LJ (2020) Distinction between euthanasia and palliative sedation is clear-cut. J Med Ethics 46(1):55–56

    PubMed  Google Scholar 

  94. Levy MH, Cohen SD (2005) Sedation for the relief of refractory symptoms in the imminently dying: a fine intentional line. Semin Oncol 32(2):237–246

    PubMed  Google Scholar 

  95. Hasselaar JG, Reuzel RP, van den Muijsenbergh ME, Koopmans RT, Leget CJ, Crul BJ et al (2008) Dealing with delicate issues in continuous deep sedation. Varying practices among Dutch medical specialists, general practitioners, and nursing home physicians. Arch Intern Med 168(5):537–543

    PubMed  Google Scholar 

  96. Kuhse H, Singer P, Baume P, Clark M, Rickard M (1997) End-of-life decisions in Australian medical practice. Med J Aust 166(4):191–196

    CAS  PubMed  Google Scholar 

  97. Stevens CA, Hassan R (1994) Management of death, dying and euthanasia: attitudes and practices of medical practitioners in South Australia. Arch Intern Med 154(5):575–584

    Google Scholar 

  98. Willems DL, Daniels ER, van der Wal G, van der Maas PJ, Emanuel EJ (2000) Attitudes and practices concerning the end of life: a comparison between physicians from the United States and from The Netherlands [In Process Citation]. Arch Intern Med 160(1):63–68

    CAS  PubMed  Google Scholar 

  99. Meier DE, Emmons CA, Wallenstein S, Quill T, Morrison RS, Cassel CK (1998) A national survey of physician-assisted suicide and euthanasia in the United States [see comments]. N Engl J Med 338(17):1193–1201

    CAS  PubMed  Google Scholar 

  100. Douglas CD, Kerridge IH, Rainbird KJ, McPhee JR, Hancock L, Spigelman AD (2001) The intention to hasten death: a survey of attitudes and practices of surgeons in Australia. Med J Aust 175(10):511–515

    CAS  PubMed  Google Scholar 

  101. Rietjens JA, van der Heide A, Vrakking AM, Onwuteaka-Philipsen BD, van der Maas PJ, van der Wal G (2004) Physician reports of terminal sedation without hydration or nutrition for patients nearing death in the Netherlands. Ann Intern Med 141(3):178–185

    PubMed  Google Scholar 

  102. Billings JA, Block SD (1996) Slow euthanasia. J Palliat Care 12(4):21–30

    CAS  PubMed  Google Scholar 

  103. Fainsinger RL, De Moissac D, Mancini I, Oneschuk D (2000) Sedation for delirium and other symptoms in terminally ill patients in Edmonton. J Palliat Care 16(2):5–10

    CAS  PubMed  Google Scholar 

  104. Murray SA, Boyd K, Byock I (2008) Continuous deep sedation in patients nearing death. BMJ. 336(7648):781–782

    PubMed Central  PubMed  Google Scholar 

  105. Higgins PC, Altilio T (2007) Palliative sedation: an essential place for clinical excellence. J Soc Work End Life Palliat Care 3(4):3–30

    PubMed  Google Scholar 

  106. Reuzel RP, Hasselaar GJ, Vissers KC, van der Wilt GJ, Groenewoud JM, Crul BJ (2008) Inappropriateness of using opioids for end-stage palliative sedation: a Dutch study. Palliat Med 22(5):641–646

    CAS  PubMed  Google Scholar 

  107. Hasselaar JG, Reuzel RP, Verhagen SC, de Graeff A, Vissers KC, Crul BJ (2007) Improving prescription in palliative sedation: compliance with Dutch guidelines. Arch Intern Med 167(11):1166–1171

    PubMed  Google Scholar 

  108. Rietjens JA, Hauser J, van der Heide A, Emanuel L (2007) Having a difficult time leaving: experiences and attitudes of nurses with palliative sedation. Palliat Med 21(7):643–649

    PubMed  Google Scholar 

  109. Craig GM (1996) On withholding artificial hydration and nutrition from terminally ill sedated patients. The debate continues [published erratum appears in J Med Ethics 1996 Dec;22(6):361]. J Med Ethics 22(3):147–153

    CAS  PubMed Central  PubMed  Google Scholar 

  110. Craig GM (1994) On withholding nutrition and hydration in the terminally ill: has palliative medicine gone too far? [see comments]. J Med Ethics 20(3):139–143 discussion 44-5

    CAS  PubMed Central  PubMed  Google Scholar 

  111. Craig G (1994) Is sedation without hydration or nourishment in terminal care lawful? Med Leg J 62(Pt 4):198–201

    PubMed  Google Scholar 

  112. Orentlicher D (1997) The Supreme Court and physician-assisted suicide--rejecting assisted suicide but embracing euthanasia. N Engl J Med 337(17):1236–1239

    CAS  PubMed  Google Scholar 

  113. Hahn MP (2012) Review of palliative sedation and its distinction from euthanasia and lethal injection. J Pain Palliat Care Pharmacother 26(1):30–39

    PubMed  Google Scholar 

  114. Sulmasy DP, Ury WA, Ahronheim JC, Siegler M, Kass L, Lantos J et al (2000) Palliative treatment of last resort and assisted suicide. Ann Intern Med 133(7):562–563

    CAS  PubMed  Google Scholar 

  115. Chiu T-Y, Hu W-Y, Chuang R-B, Chen C-Y (2002) Nutrition and hydration for terminal cancer patients in Taiwan. Support Care Cancer 10:630–636

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

NC and BZW contributed to the conceptualization and writing of the manuscript and final review.

Corresponding author

Correspondence to Nathan I. Cherny.

Ethics declarations

Ethical approval

Not relevant

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cherny, N.I., Ziff-Werman, B. Ethical considerations in the relief of cancer pain. Support Care Cancer 31, 414 (2023). https://doi.org/10.1007/s00520-023-07868-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00520-023-07868-3

Keywords

Navigation